Stable knockdown of CREB, HIF-1 and HIF-2 by replication-competent retroviruses abrogates the responses to hypoxia in hepatocellular carcinoma

Inhibition of cyclic AMP response element-directed transcription by decoy oligonucleotides enhances tumor-specific radiosensitivity

(2016) Serk In Park et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Extracellular Signal-Regulated Kinase 5 and Cyclic AMP Response Element Binding Protein Are Novel Pathways Inhibited by Vandetanib (ZD6474) and Doxorubicin in Mesotheliomas

(2014) Mutlay Sayan et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Radiosensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector

(2014) M Takahashi et al.   CANCER GENE THERAPY

Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model

(2013) T T Huang et al.   CANCER GENE THERAPY

Angiopoietin2 enhances doxorubin resistance in HepG2 cells by upregulating survivin and Ref-1 via MSK1 activation

(2013) Tao Li et al.   CANCER LETTERS

Hypoxia as a target for tissue specific gene therapy

(2013) Taiyoun Rhim et al.   JOURNAL OF CONTROLLED RELEASE

Increased glutathione and mitogen-activated protein kinase phosphorylation are involved in the induction of doxorubicin resistance in hepatocellular carcinoma cells

(2012) Cai-Guo Ye et al.   HEPATOLOGY RESEARCH

Anthracycline Inhibits Recruitment of Hypoxia-inducible Transcription Factors and Suppresses Tumor Cell Migration and Cardiac Angiogenic Response in the Host

(2012) Tetsuhiro Tanaka et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Downregulating hypoxia-inducible factor-2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma

(2011) Changjun He et al.   CANCER SCIENCE

HCC and angiogenesis: possible targets and future directions

(2011) Andrew X. Zhu et al.   Nature Reviews Clinical Oncology

Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene

(2010) C-K Tai et al.   CANCER GENE THERAPY

Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis

(2010) X. Lu et al.   CLINICAL CANCER RESEARCH

Hypoxia-Inducible Factors and the Response to Hypoxic Stress

(2010) Amar J. Majmundar et al.   MOLECULAR CELL

Doxorubicin causes diaphragm weakness in murine models of cancer chemotherapy

(2010) Laura A.A. Gilliam et al.   MUSCLE & NERVE

Selective gene silencing by viral delivery of short hairpin RNA

(2010) Katja Sliva et al.   Virology Journal

Differential Effects of Hypoxic Stress in Alveolar Epithelial Cells and Microvascular Endothelial Cells

(2009) Sara Signorelli et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Vascular Changes in Hepatocellular Carcinoma

(2008) Zhen Fan Yang et al.   Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology

Growth Suppression of Lung Cancer Cells by Targeting Cyclic AMP Response Element-Binding Protein

(2008) S. Aggarwal et al.   CANCER RESEARCH

t-Darpp Promotes Cancer Cell Survival by Up-regulation of Bcl2 through Akt-Dependent Mechanism

(2008) A. Belkhiri et al.   CANCER RESEARCH

A Key Role for Cyclic AMP-Responsive Element Binding Protein in Hypoxia-Mediated Activation of the Angiogenesis Factor CCN1 (CYR61) in Tumor Cells

(2008) R. Meyuhas et al.   MOLECULAR CANCER RESEARCH

Replication-competent retrovirus vectors for cancer gene therapy

(2007) Chien-Kuo Tai   Frontiers in Bioscience-Landmark